Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
By Krishna N. DasNEW DELHI, Nov 17 (Reuters) - India hopes five locally-tested vaccines will help it to control COVID-19, as those developed by Pfizer and Moderna may not be available to it in big quantities soon.The five candidates include Russia...
Read moreLONDON, Nov 16 (Reuters) - The government will have to consider strengthening the three-tier system of restrictions used to control the spread of COVID-19 when the full lockdown in England ends, a medical adviser said on Monday."We see very little...
Read moreLONDON, Nov 16 (Reuters) - No one has looked at the data of AstraZenca’s potential COVID-19 vaccine yet to see if it will be effective, England’s Deputy Chief Medical Officer Jonathan Van-Tam said on Monday."Whether any vaccine is going to work is...
Read moreLONDON, Nov 16 (Reuters) - Britain has secured 5 million doses of Moderna's experimental COVID-19 vaccine after interim data indicated it was 94.5% effective, health minister Matt Hancock said on Monday."We have today secured an initial agreement ...
Read moreBy Danilo MasoniMILAN, Nov 16 (Reuters) - Shares in Pfizer fell on Monday after rival drugmaker Moderna said its experimental vaccine against COVID-19 was 94.5% effective and that it can be stored at normal fridge temperatures.Moderna is the secon...
Read more* Deal with CureVac for 405 mln COVID-19 vaccine doses* Financial terms not disclosed* Commission hopes to finalise deal with Moderna (Adds detail)By Francesco GuarascioBRUSSELS, Nov 16 (Reuters) - The European Union has struck a deal for up 405 mi...
Read more(Adds quote)BRUSSELS, Nov 16 (Reuters) - The European Commission will authorise a deal with German biotech firm CureVac on Tuesday to secure up to 405 million doses of its potential COVID-19 vaccine, the head of the European Commission, Ursula vo...
Read moreBRUSSELS, Nov 16 (Reuters) - The European Commission will authorise on Tuesday a deal with biotech firm CureVac to secure up to 405 million doses of its potential COVID-19 vaccine, the head of the European Commission Ursula von der Leyen said on ...
Read more* Moderna deal is Britain's seventh supply deal* Health minister: we prioritised vaccines with early availability* Medical official says good trial results bode well for others (Recasts with Hancock confirming deal)By William James and Alistair Sm...
Read more(Adds details from PM's spokesman)LONDON, Nov 16 (Reuters) - Britain said it was in advanced talks to access an experimental COVID-19 vaccine developed by Moderna Inc after it reported positive trial results on Monday, adding it would be available...
Read moreLONDON, Nov 16 (Reuters) - Britain said it was in advanced talks to access an experimental COVID-19 vaccine developed by Moderna Inc, which interim data on Monday indicated was 94.5% effective."As part of the ongoing work of the Vaccines Taskforce...
Read more* Moderna vaccine 94.5% effective in interim trial data* No severe COVID-19 cases in trial participants with shot* Moderna vaccine easier to transport than Pfizer's* Globals stocks hit record high* Experts encouraged by Moderna results (Updates shar...
Read more* Moderna vaccine 94.5% effective in interim trial data* No severe COVID-19 cases in trial participants with shot* Moderna vaccine easier to transport than Pfizer's* Globals stocks hit record high* Experts encouraged by Moderna results (Updates shar...
Read more* Moderna vaccine 94.5% effective in interim trial data* No severe COVID-19 cases in trial participants with shot* Moderna vaccine easier to transport* Stocks markets head for record high* Experts encouraged by Moderna results: (Adds Fauchi, updates...
Read more* Moderna vaccine 94.5% effective in interim trial data* No severe COVID-19 cases in trial participants with shot* Stocks markets head for record high* Experts encouraged by Moderna results: (Adds graphic, bullet points, more comment, updates shares...
Read more
Last checked at